Sclerosis multiplex (SM): vizsgálatok itt: Franciaország

In Franciaország 71 Also abroad 506

71 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Where
Ajaccio, Amiens Cedex 1, Besançon, Bron, Clermont-Ferrand, Gonesse, Grenoble Cedex 09, Lille Cedex, Limoges Cedex 1, Montpellier Cedex 5, Nancy, Nice, Nîmes, Orsay, Paris, Poitiers, Rennes Cedex 9, Rouen Cedex, Saint-Herblain, Strasbourg Cedex 2, Toulouse, Tours
Életkor
18 év and over
People
677 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00
1. fázisTaking people
MAESTRO-4MS : "Allogenic Adipose tissue-derived Mesenchymal Stromal Cells for the treatment of Primary Progressive Multiple Sclerosis: an open-label phase I clinical trial."
Where
Creteil, Rennes
Életkor
18 év to 64 év
People
15
Run by
Centre Hospitalier Universitaire De Rennes
See details and how to join2023-509538-20-01 · EU 2023-509538-20-01
3. fázisTaking people
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
Where
Ajaccio, Bayonne, Besancon Cedex, Bordeaux, Caen Cedex 9, Clermont Ferrand Cedex 1, Creteil, Dijon, La Tronche, Libourne Cedex, Lille Cedex, Marseille, Montpellier Cedex 5, Nancy, Nantes Cedex 1, Nice, Nîmes, Pau Cedex, Poissy, Rennes, Rouen Cedex, Strasbourg Cedex 2, Suresnes, Toulouse, Tours
Életkor
40 év and over
People
250
Run by
University Hospital, Montpellier
See details and how to joinNCT07189325 · EU 2024-513292-40-00
No phaseTaking people
Diagnostic Value of eVOG
Where
Nice
Életkor
18 év and over
People
150
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT05776511
No phaseNot yet taking people in Franciaország
PRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple Sclerosis
Where
Angers, Antibes, Bordeaux, Brest, Caen, Clermont-Ferrand, Colmar, Créteil, Dijon, Épinal, Grenoble, La Roche-sur-Yon, Lille, Lyon, Marseille, Metz, Montpellier, Nancy, Nice, Nîmes, Paris, Poissy, Poitiers, Rennes, Rouen, Saint-Brieuc, St-Malo, Strasbourg, Toulouse, Tours, Vannes
Életkor
18 év to 50 év
People
448
Run by
Nantes University Hospital
See details and how to joinNCT07647952
No phaseNot yet taking people in Franciaország
Internuclear Ophthalmoplegia and Multiple Sclerosis: a Multicenter Retrospective Study
Where
Strasbourg
Életkor
18 év and over
People
200
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07560995
No phaseTaking people
Deployment o the Multidisciplinary Prospective Cohort Imminent
Where
Lille
Életkor
18 év and over
People
2200
Run by
University Hospital, Lille
See details and how to joinNCT04334031
No phaseTaking people
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
Where
Poitiers
Életkor
18 év and over
People
50
Run by
Poitiers University Hospital
See details and how to joinNCT05491031
No phaseNot yet taking people in Franciaország
Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?
Where
Colmar, Dijon, Haguenau, Metz, Mulhouse, Nancy, Reims, Strasbourg
Életkor
18 év to 70 év
People
136
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07545889
No phaseTaking people
How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.
Where
Paris
Életkor
18 év and over
People
57
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07289724
3. fázisTaking people
For patients with active multiple sclerosis, impact of annual versus semi-annual infusions of ocrelizumab after 2 years of initial treatment on the absence of radiological disease activity at 2 years: a multicentre randomised controlled non-inferiority trial
Where
Bron, Creteil Cedex, Gonesse, Grenoble Cedex 09, Limoges Cedex 1, Nice, Paris, Paris Cedex 13, Poissy, Strasbourg Cedex 2, Suresnes
Életkor
18 év and over
People
244
Run by
Hopital Fondation Adolphe De Rothschild
See details and how to join2023-505420-62-00 · EU 2023-505420-62-00
No phaseTaking people
EXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis
Where
Berck, Créteil, Dijon, Gaillac-Toulza, Garches, Lomme, Lyon, Nice, Rennes, Saint-Genis-Laval, Strasbourg
Életkor
18 év and over
People
77
Run by
Otto Bock France SNC
See details and how to joinNCT07252895
No phaseTaking people
Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life
Where
Ars-Laquenexy, Nancy
People
100
Run by
Central Hospital, Nancy, France
See details and how to joinNCT07492667
No phaseTaking people
Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis
Where
Lille
Életkor
18 év to 65 év
People
30
Run by
SYSNAV
See details and how to joinNCT07388992
No phaseTaking people
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
Where
Nantes
Életkor
18 év and over
People
130
Run by
Nantes University Hospital
See details and how to joinNCT04873492
No phaseTaking people
Common and Specific Information From Neuroimaging and Smartphone
Where
Nantes
Életkor
18 év and over
People
100
Run by
Nantes University Hospital
See details and how to joinNCT05482906
No phaseTaking people
Exploring Cortical Remyelination in Children With Multiple Sclerosis
Where
Le Kremlin-Bicêtre, Paris
Életkor
12 év to 18 év
People
40
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05258396
2/3. fázisTaking people
Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)
Where
Bron, Orsay Cedex, Paris Cedex 13, Rennes, Rennes Cedex, Toulouse, Vandoeuvre Les Nancy
Életkor
18 év to 64 év
People
41
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06280742 · EU 2023-510304-53-00
No phaseTaking people
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
Where
Paris
Életkor
18 év to 99 év
People
113
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05772637
3. fázisTaking people
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Where
Brest Cedex 2, Bron Cedex, Caen Cedex 9, Clermont-Ferrand, Creteil Cedex, Gonesse, Grenoble Cedex 9, Limoges, Lomme Cedex, Marseille, Montpellier Cedex 5, Nancy, Nice, Nimes Cedex 9, Paris, Poissy, Poitiers, Pontoise, Quimper Cedex, Rennes, Rouen Cedex, Saint-Herblain, Saint-Malo Cedex, Strasbourg Cedex, Suresnes, Toulouse
Életkor
18 év to 55 év
People
386
Run by
Rennes University Hospital
See details and how to joinNCT05758831 · EU 2022-501027-25-01
No phaseTaking people
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
Where
Nice
Életkor
18 év to 60 év
People
150
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07135752
No phaseTaking people
French Registry for Monitoring Pregnancies for Multiple Sclerosis
Where
Amiens, Annecy, Avignon, Besançon, Bordeaux, Brive-la-Gaillarde, Bron, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon, Épinal, Garches, Gonesse, Grenoble, Le Chesnay, Lille, Limoges, Lyon, Marseille, Montpellier, Mornant, Nancy, Nice, Nîmes, Paris, Poissy, Poitiers, Pontoise, Rennes, Rouen, Saint-Denis, Saint-Herblain, Saint-Lô, Saint-Priest-en-Jarez, Strasbourg, Suresnes, Toulouse, Tours, Villeurbanne
People
1500 worldwide
Run by
Hospices Civils de Lyon
See details and how to joinNCT03900221
No phaseTaking people
Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research
Where
Paris
Életkor
18 év and over
People
200
Run by
Fondation Ophtalmologique Adolphe de Rothschild
See details and how to joinNCT04906928
No phaseTaking people
Detection of Spinal Cord Lesions Using the MP2RAGE Sequence in Inflammatory Diseases of the Neuraxis
Where
Paris
Életkor
18 év and over
People
196
Run by
Fondation Ophtalmologique Adolphe de Rothschild
See details and how to joinNCT06589999
1. fázisTaking people
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
Where
Créteil, Rennes
Életkor
18 év to 55 év
People
10
Run by
Rennes University Hospital
See details and how to joinNCT06592703